Skip to main content

Advertisement

Table 2 Demographic and clinical features of patients with NAFLD and controls.

From: Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study

  Italian controls Italian adult NAFLD
number 346 202
Sex F 74 (21) 41 (20)
Age years 47.7 ± 12 47.4 ± 11
BMI Kg/m2 25.1 ± 2.6* 27.4 ± 3.8*
Total cholesterol mg/dl 194 ± 34* 211 ± 43*
HDL cholesterol mg/dl 56.2 ± 13* 45.1 ± 12*
Triglycerides mg/dl 89 ± 43* 158 ± 91*
Fasting insulin IU/ml 13.4 ± 7* 16.8 ± 11*
Glucose mg/dl 88.5 ± 10* 98 ± 24*
HOMA-IR 2.9 ± 1.6* 4.1 ± 3.3*
ALT UI/ml 23 ± 9* 65 ± 46*
GGT UI/ml 23 ± 16* 87 ± 96*
Fibrosis stage F0/F1/F2/F3/F4 - 104/61/23/8/6 (52/30/11/4/3)
  1. * p < 0.0001 between Italian patients and controls, ():% values